The Testosterone Question
T clinics are everywhere. Marketing promises energy, vitality, youth. But what does the evidence actually say? When does TRT help, and when is it hype?
Testosterone declines naturally with age—about 1-2% per year after 30. This is normal physiology, not disease. The multi-billion dollar TRT industry has convinced many men they need treatment for normal aging. True hypogonadism exists and benefits from treatment. But most men being treated don't have it.
The Natural Decline
Testosterone Levels by Age
Average total testosterone with normal range bands
Source: Travison et al., J Clin Endocrinol Metab 2017; Harmonized reference ranges
What Actually Affects Testosterone
📉 What Lowers T
- Obesity: Fat converts T to estrogen. Losing weight often raises T significantly.
- Sleep deprivation: One week of 5hr nights drops T 10-15%
- Opioids: Very common cause of low T; often missed
- Chronic illness: Diabetes, liver disease, kidney disease
- Sleep apnea: Treating it often raises T
- Stress/depression: Cortisol suppresses T production
- Age: Gradual decline is normal
📈 What Actually Raises T (Naturally)
- Weight loss: Losing fat is the most effective intervention
- Sleep optimization: 7-9 hours consistently
- Resistance training: Modest but real effect
- Treat sleep apnea: Often normalizes T
- Stop opioids: If medically possible
- Reduce stress: Lower cortisol, higher T
- Adequate zinc/vitamin D: Only if deficient
TRT: What the Evidence Says
The TRAVERSE trial (2023) was the largest safety study of TRT—over 5,000 men followed for years. It settled the cardiovascular safety question but also clarified what TRT does and doesn't do.
| Outcome | Evidence | Effect Size | Notes |
|---|---|---|---|
| Sexual function | Moderate benefit | Modest improvement | Libido and erections improve; not dramatic |
| Anemia | Clear benefit | Increases hemoglobin | Erythrocytosis is actually a side effect |
| Bone density | Moderate benefit | Modest increase | Relevant for osteoporosis |
| Body composition | Small benefit | Small changes | Slight more muscle, less fat |
| Energy/vitality | Minimal benefit | Not better than placebo | The marketing promise; doesn't deliver |
| Mood/depression | Inconsistent | Mixed results | Not a depression treatment |
| Cognitive function | No benefit | No improvement | Doesn't help memory or cognition |
| Cardiovascular safety | Neutral | No increased risk | TRAVERSE: non-inferior to placebo |
T Clinic Red Flags
Appropriate vs. Inappropriate TRT Workup
What should happen before starting testosterone
Source: Endocrine Society Clinical Practice Guideline 2018
🚩 Red Flags at T Clinics
- Diagnosis based on single test (need at least 2)
- Not checking morning levels (T peaks in AM)
- Targeting "optimal" not normal ranges
- Not investigating underlying causes
- Prescribing without symptoms (just low number)
- Aggressive upselling of add-ons (HCG, AI, etc.)
- Cash-only, no insurance accepted
✅ Appropriate Workup
- Two morning testosterone levels
- Check free or bioavailable T (not just total)
- Measure LH/FSH to determine cause
- Evaluate for sleep apnea
- Screen for obesity, depression, opioid use
- Trial of lifestyle optimization first
- Shared decision-making about benefits/risks
✓ Your Testosterone Action Plan
📌 The Bottom Line
Decline Is Normal
1-2% per year after 30 is physiology, not disease. Most men don't need treatment.
Fix Underlying Causes
Obesity, sleep apnea, opioids—address these first. T often normalizes.
Benefits Are Modest
TRT helps sexual function and anemia. Energy/vitality improvements don't beat placebo.
Be Clinic-Skeptical
T clinics profit from overdiagnosis. Demand proper workup and realistic expectations.
Sources & Further Reading
- Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy (TRAVERSE). N Engl J Med. 2023;389(2):107-117.
- Snyder PJ, et al. Effects of testosterone treatment in older men (TTrials). N Engl J Med. 2016;374(7):611-624.
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
- Travison TG, et al. Harmonized reference ranges for circulating testosterone levels in men. J Clin Endocrinol Metab. 2017;102(4):1161-1173.